Announcements Trials
Browse Landscape

Status

Completed 165Recruiting 33Active not recruiting 33Terminated 30Unknown 18Not yet recruiting 13Withdrawn 12No longer available 1Enrolling by invitation 1Available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Glioblastoma 11Neuroblastoma 6Glioma 6Pheochromocytoma 3Paraganglioma 2Melanoma 2Diffuse Intrinsic Pontine Glioma 2Wilms Tumor 1Thyroid cancer, medullary 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Neoplasms 1Meningeal Neoplasms 1Meningeal Carcinomatosis 1Medulloblastoma 1Insulinoma 1Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Dysbiosis 1Disease Progression 1Disease 1Carcinoid Tumor 1Breast Neoplasms 1

Interventions

omburtamab I-131 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Medulloblastoma × CNS × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡